Our network of collaborations

Several of our studies rely heavily on the collaboration with the following researchers

In Pisa

  • Prof. Ugo Boggi, Head Division of Surgery, Pisa, Italy.
    We are collaborating on the Tuscany Tumor Institute and Italian Association Studies on Cancer grants on genetics and epigenetics factors in PDAC resistance. We already co-authored 25 referred articles.
    Website: www.ugoboggi.com
  • Prof. Alfredo Falcone, Head Division of Oncology, Dr. Sara Caponi and Dr. Enrico Vasile, University of Pisa, Pisa.
    We are collaborating on two Tuscany Tumor Institute grants. We already co-authored 12 referred articles.
    Website: www.unimap.unipi.it
  • Prof. Filippo Minutolo, Associate Professor of Medicinal Chemistry, University of Pisa.
    We are collaborating on the Mesothelioma Applied Research Foundation and the EORTC-PAMM grants. We already co-authored 8 referred articles.
    Website: www.unimap.unipi.it
  • Dr. Ranieri Bizzarri, CNR Nano, Istituto di nanoscienze, NEST.
    We are collaborating on the FAS grant “DIAMANTE” on molecular diagnostics and new therapeutic approaches in PDAC.
    Website: www.nano.cnr.it

In Italy

  • Prof. Andrea Ardizzoni, Head Department of Oncology, Bologna University Hospital.
    We are collaborating on novel EGFR inhibitors and pharmacogenetic studies (partly funded by AIRC). We already co-authored 5 referred articles.
    Website: www.aosp.bo.it
  • Dr. Cantore, Dr. Mambrini and Dr. Pacetti, Department of Oncology, Carrara Civic Hospital, Carrara.
    We are collaborating on pharmacogenetic studies on PDAC. We already co-authored 5 referred articles.
  • Dr. Federico Cappuzzo, Department of Oncology, Livorno Civil Hospital, Livorno.
    We already co-authored 2 referred articles.
    Website: www.esmo.org
  • Dr. Cecilia Ceresa, Department of Surgery and Interdisciplinary Medcine University of Milano-Bicocca.
    We are collaborating on neurotoxicity of anticancer agents. We already co-authored 3 referred articles.
    Website: www.enu.dcmt.unimib.it
  • Dr. Giovanni Codacci-Pisanelli, Department of Medical and Surgical Sciences and Biotechnology Sapienza University of Rome, Rome.
    We are collaborating on studies on chemotherapeutic drugs in breast-milk. We already co-authored 3 referred articles.
    Website: www.gomppublic.uniroma1.it
  • Dr. Tommaso De Pas and Dr. Francesca Toffalorio, European Institute of Oncology, Milano.
    We are collaborating on pharmacogenetic studies in lung cancer. We already co-authored 5 referred articles.
    Website: www.ieo.it
  • Dr. Ingrid Garajova, Dr. G Brandi and Dr. G. Biasco, Department of Experimental, Diagnostic and Speciality Medicine, University of Bologna, Sant’Orsola-Malpighi Hospital, Bologna, Italy
    We are collaborating on miRNA studies in pancreatic and lung cancer. We already co-authored 3 referred articles.
  • Dr. Michele Milella, Division of Medical Oncology, Istituto Nazionale Tumori Regina Elena, Roma.
    We are collaborating on pharmacogenetic studies on PDAC. We already co-authored 2 referred articles.
    Website: www.ifo.it
  • Dr. Fedro Peccatori, Director, Fertility & Procreation in Oncology Unit, Department of Medicine, European Institute of Oncology, Milano.
    We are collaborating on studies on chemotherapeutic drugs in breast-milk. We already co-authored 3 referred articles.
    Website: www.cancerworld.org
  • Prof. Piergiorgio Petronini, Dr. Roberta Alfieri, Dr. Andrea Cavazzoni and Dr. Marcello Tiseo. Department of Experimental Pathology and Medical Oncology, University of Parma.
    We are collaborating on novel antitargeted agents in lung cancer (partly funded by AIRC). We already co-authored 6 referred articles.
    Website: www.unipr.it
  • Dr. Michele Reni, Department of Oncology, San Raffaele Scientific Institute, Milano.
    We are collaborating on pharmacogenetic studies on PDAC. We already co-authored 3 referred articles.
    Website: www.hsr.it
  • Dr. Carmela Maria Santarpia. Department of Pathology. University of Messina.
    We are collaborating on pharmacogenetic studies in lung cancer. We already co-authored 2 referred articles.
    Website: www.unime.it
  • Dr. Libero Santarpia. Oncology Experimental Therapies Lab. Humanitas Clinical and Research Center, Milano, Italy.
    We are collaborating on studies on microRNA (partly funded by AIRC). We already co-authored 2 referred articles.
    Website: www.humanitas-research.org
  • Dr. Armando Santoro, Head Department of Oncology and Hematology, and Dr. Paolo A. Zucali, Humanitas Hospital, Milano.
    We are collaborating on the grant of Fondazione Humanitas and on the Mesothelioma Applied Research Foundation grant. We already co-authored 9 referred articles.
    Website: www.humanitas.it
  • Dr. Carmelo Tibaldi, Department of Oncology, AUSL 2, Lucca.
    We are collaborating on pharmacogenetic studies on thoracic tumors. We already co-authored 11 referred articles.
    Website: www.ittumori.it

In Europe, US and the rest of the world

  • Dr. Asif Ali, Researcher at Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, UK.
    We are collaborating on studies on microRNAs in PDAC. We already co-authored one abstract at the AACR meeting.
    Website: www.gla.ac.uk
  • Prof. Yehuda Assaraf, Dean of the Faculty of Biology, Head Pharmacology Lab, Department of Biology, The Technion-Israel Institute of Technology, Haifa, Israel, and VUmc Guest Professor.
    We are collaborating on the CCA grant on Splicing mechanisms involved in drug resistance. We already co-authored 3 referred articles.
    Website: www.assaraflab.net
  • Dr. Maarten Bijlsma, Prof. Hanneke van Laarhoven. Department of Oncology and LEXOR lab, AMC, Amsterdam.
    We are collaborating on studies on phosphoproteomics and signaling in pancreatica cancer (funded by AIO-Alliantie grant).
    Website: www.amc.nl
  • Dr. Viola Caretti, PostDoc in the “Monje Lab”, Department of Neurology and Neurological sciences. Stanford School of Medicine, Paolo Alto, CA, US.
    We are collaborating on new tumor models. We already co-authored 2 referred articles.
    Website: www.neurology.stanford.edu
  • Dr. Joseph Ciccolini, Pharmacokinetics Unit, Aix-Marseille University, Marseille, France.
    We are collaborating on the EORTC-PAMM studies to validate CDA activity methods. We already co-authored 3 referred articles.
  • Dr. Adam E Frampton, Department of Surgery and Cancer, HPB Surgical Unit, Imperial College, London, UK.
    We are collaborating on studies on microRNAs. We already co-authored 13 referred articles.
    Website: www.imperial.ac.uk
  • Prof. Giuseppe Giaccone, Associate Director, Lombardi Comprehensive Cancer Center (LCCC), Georgetown University, Washington, US.
    We are collaborating on PDAC and lung cancer genetics and pharmacological studies. We already co-authored 11 referred articles.
    Website: www.explore.georgetown.edu
  • Dr. Clara Lemos, PostDoc in the “Tumor Metastasis and Therapy Response” group, Charité – Universitätsmedizin, Berlin.
    We are collaborating on studies on drug resistance and new anticancer agents. We already co-authored 5 referred articles.
    Website: www.charite-buch.de
  • Dr. Leticia G Leon, Instituto Universitario de Bio-Organica Antonio Gonzalez (IUBO-AG), Universidad de La Laguna, C/Astrofísico Francisco Sanchez, La Laguna, Spain.
    We are collaborating on the Mesothelioma Foundation, and European Union FP7-REGPOT-2012-2013-1 Cal IMBRAIN grant n° 4319786. We already co-authored 18 referred articles.
    Website: www.ull.es
  • Prof. Godefridus J Peters, Dr. Jacqueline Cloos, Dr. Connie Jimenez, Prof. Geert Kazemier, Dr. Thomas Wurdinger, Prof. Henk Verheul, VU University Medical Center, Amsterdam.
    We are collaborating on the CCA, EORTC-PAMM, Mesothelioma Foundation, and European Union FP7-REGPOT-2012-2013-1 Cal IMBRAIN grant n° 4319786 grants. We already co-authored more than 90 referred articles.
    Website: www.vumc.com
  • Dr. Karl Quint, Institute for Surgical Research, Marburg University, Marburg, Germany.
    We are collaborating on the Pancreas2000 project. We already co-authored 1 referred article.
  • Prof. Josè Antonio Rodriguez, School of Medicine and Dentistry, University of the Basque Country, Bilbao, Spain.
    We are collaborating on pharmacological studies on lung cancer. We already co-authored 3 referred articles.
    Website: www.ehu.es
  • Prof. Christian Rolfo, Head Phase I – Early Clinical Trials group, Dept. Oncology University Hospital Antwerp, Belgium.
    We are collaborating on studies on novel biomarkers in lung cancer and PDAC. We already co-authored 4 referred articles and submitted 2 clinical protocols at the Ethic Committee of the University Hospital of Antwerp, Belgium.
    Website: www.uza.be
  • Arjan Van der Velde, Bioinformatics PhD Candidate at Boston University, Boston, MD, US (now at Weng Lab, UMass Medical Center).
    We already co-authored 3 referred articles.
    Website: www.zlab.umassmed.edu
  • Dr. Amir Avan, Researcher at Molecular Medicine Group,Department of New Sciences and Technology, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran
    We are collaborating on studies on new anticancer drugs and models in pancreatic cancer (funded by CCA grant). We already co-authored 20 articles.
    Website: www.mums.ac.ir